MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Interventions"

  • 2024 International Congress

    Randomized Controlled Trial of Supplementary Motor Area Transcranial Direct Current Stimulation in Tourette Syndrome

    Y. Mahjoub, N. Szejko, L. Gan, J. Adeoti, M. Nitsche, C. Vicario, T. Pringsheim, D. Martino (Calgary, Canada)

    Objective: To investigate the effect of cathodal transcranial direct current stimulation (tDCS) over the supplementary motor area (SMA) on tic severity in Tourette syndrome (TS).…
  • 2023 International Congress

    Serotonin Coma: An Antipodal emergency

    K C. Chudasama, V J. Jhala (Rajkot, India)

    Objective: To highlight the severity of Serotonin syndrome precipitated in a Psychiatric patient on two unique serotonergic medications leading to a comatose state. Background: Serotonin…
  • 2023 International Congress

    Movement Disorders (MD) Specialist Nurse pilot project in Australia’s Northern Territory (NT): One year of experience.

    Y. Hernandez Gomez (Darwin, Australia)

    Objective: The MD Specialist Nurse, a project funded by the Commonwealth of Australia started 1 year ago to provide access to specialist nursing care and…
  • 2023 International Congress

    Chinese proprietary medicine as adjunct treatment for Parkinson’s disease: a systematic review and meta-analysis

    S. Yuen, KK. Chua, SC. Chen, CP. Ho, C. Chan, M. Li (Hong Kong, Hong Kong)

    Objective: To evaluate the effectiveness of Chinese proprietary medicine (CPM) in improving outcomes of Parkinson’s disease (PD). Background: CPM is a finished Chinese herbal medicine…
  • 2023 International Congress

    Non-intrusive Video-Based Solution for Continuous Quantitative Monitoring of Parkinson’s Patients’ Motor Functions

    A-S. Bridoux, G. Altares, G. Garraux, M. Koivu, L. Mäkitie, E. Fiorenzato, L. Weis, A. Antonini, A. Nieuwboer (Mons, Belgium)

    Objective: Feasibility and preliminary validation of a marker-less solution for automatic capture and quantification of movements during prespecified tasks of people with Parkinson’s (PwP) using…
  • 2023 International Congress

    Be aware of Involuntary Emotional Expressive Disorder: a neurological syndrome, not a mood disorder

    V. Balasubramaniam, L. Baytieh (WOLLONGONG, Australia)

    Objective: To increase awareness of Involuntary Emotional Expressive Disorder (IEED) in clinicians assessing patients affected with involuntary laughter and/or crying variants (in stroke and traumatic…
  • 2023 International Congress

    Chinese herbal medicine treatment based on subgroup differentiation as adjunct therapy for Parkinson’s disease: interim analysis of a pilot add-on, randomized, controlled, pragmatic clinical trial

    S. Yuen, KK. Chua, L. Zhong, KW. Chan, C. Chan, CP. Ho, KL. Chan, E. Han, K. Pang, ZX. Lin, V. Mok, N. Cheung, AY. Lau, M. Li (Hong Kong, Hong Kong)

    Objective: This interim data analysis preliminarily evaluated the feasibility and effectiveness of protocolized CHM on motor-related daily living of PD patients. Background: A Chinese national…
  • 2023 International Congress

    Development and quantified evaluation of a continuous smartphone app-based monitoring approach to individualize Parkinson’s disease management.

    F. Thieken, S. Wattendorf, P. Korn, M. Kontz, O. Ataiy, P. Fischer, MO. Ashraf, V. Gross, D. Pedrosa, K. Sohrabi, L. Timmermann (Marburg, Germany)

    Objective: The aim of this study is the development and qualified evaluation of a smartphone app-based application to enable a longitudinal assessment of Parkinson’s disease…
  • 2023 International Congress

    Curved Trajectories in Stereotactic Neurosurgery

    A. Zemmar, J. Neimat, Y. Chitalia (Louisville, USA)

    Objective: To develop a system that permits remotely navigated curved trajectories of stereotactic electrodes Background: Stereotactic neurosurgery is restricted to linear trajectories. This limits flexibility…
  • 2023 International Congress

    Observations on 5 Parkinson’s patients taking Mucuna pruriens as natural source of levodopa

    S. Elsas (Arlesheim, Switzerland)

    Objective: To explore potential benefits and tolerability of extracts from Mucuna pruriens for dopaminergic treatment of Parkinson’s patients. Background: Capsules containing freeze-dried, aqueous extract from…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 29
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley